p33(ING1) is a novel candidate tumor suppressor and its overexpression indu
ces growth arrest or apoptosis in different cell lines. These functions of
p33(ING1) depend largely on the activity of p53, and p53-dependent activati
on of the transcription from the p21/WAF1 promoter also requires p33(ING1).
We examined the expression of ING1 mRNA in breast cancer cell lines and cl
inical breast cancer tissues, using quantitative RT-PCR and real time TaqMa
n(TM) technology. In breast cancer cell lines, ING1 mRNA was expressed at a
lmost the same level. However, in a comparison between the cancer and match
ed normal tissues, a significant decrease in ING1 mRNA expression was found
in 17 of 24 (70.8%) breast cancer tissues. We also examined the correlatio
n between ING1 mRNA expression and p53 expression. There was a significant
decrease of ING1 mRNA in nine of 15 tumors negative for p53 immunostaining,
most of which were considered to have wild type p53. In these tumors, p53
may not function in case of a decreased expression of p33(ING1), and the la
ck of cell cycle regulation may correlate with the carcinogenesis and tumor
progression. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.